Skip to main navigation Skip to search Skip to main content

ULK1 inhibits the kinase activity of mTORC1 and cell proliferation

  • Chang Hwa Jung
  • , Minchul Seo
  • , Neil Michael Otto
  • , Do Hyung Kim

Research output: Contribution to journalArticlepeer-review

Abstract

ULK1 (Unc51-like kinase, hATG1) is a Ser/Thr kinase that plays a key role in inducing autophagy in response to starvation. ULK1 is phosphorylated and negatively regulated by the mammalian target of rapamycin complex 1 (mTORC1). Previous studies have shown that ULK1 is not only a downstream effector of mTORC1 but also a negative regulator of mTORC1 signaling.1-3 Here, we investigated how ULK1 regulates mTORC1 signaling, and found that ULK1 inhibits the kinase activity of mTORC1 and cell proliferation. Deficiency or knockdown of ULK1 or its homolog ULK2 enhanced mTORC1 signaling, cell proliferation rates and accumulation of cell mass, whereas overexpression of ULK1 had the opposite effect. Knockdown of Atg13, the binding partner of ULK1 and ULK2, mimicked the effects of ULK1 or ULK2 deficiency or knockdown. Both insulin and leucine stimulated mTORC1 signaling to a greater extent when ULK1 or ULK2 was deficient or knocked down. In contrast, Atg5 deficiency did not have a significant effect on mTORC1 signaling and cell proliferation. The stimulatory effect of ULK1 knockdown on mTORC1 signaling occurred even in the absence of tuberous sclerosis complex 2 (TSC 2), the negative regulator of mTORC1 signaling. In addition, ULK1 was found to bind raptor, induce its phosphorylation, and inhibit the kinase activity of mTORC1. These results demonstrate that ULK1 negatively regulates the kinase activity of mTORC1 and cell proliferation in a manner independent of Atg5 and TSC 2. The inhibition of mTORC1 by ULK1 may be important to coordinately regulate cell growth and autophagy with optimized utilization of cellular energy.

Original languageEnglish (US)
Pages (from-to)1212-1221
Number of pages10
JournalAutophagy
Volume7
Issue number10
DOIs
StatePublished - Oct 2011

Bibliographical note

Funding Information:
transferred onto immunoblot polyvinylidene difluoride (PVDF) We thank M. Kundu, N. Mizushima and D. Kwiatkowski membranes (Bio-Rad, 1620177) and detected with chemilumi-for ULK1, Atg5 and TSC2 MEFs; A. Lange, T. Neufeld and nescence reagents (Perkin-Elmer, NEL105001). Kim lab members for comments on manuscript. This study Lentiviral preparation, viral infection and stable cell line was supported by Minnesota Medical Foundation, Grant-In-generation. Lentiviral vector pLKO.1 encoding shRNA that tar-Aid, Minnesota Obesity Center (3P30DK050456), American gets ULK1, ULK2 or Atg13 or shRNA of a scrambled sequence Diabetes Association (7-07-CD-08) and NIH (T32AG029796, was introduced into HEK293T with lentiviral packaging vectors DK072004 and DK083474). pHR’8.2ΔR and pCMV-VSV-G using FuGENE 6. Viruses were collected 60 h after transfection and target cells were infected with the collected viruses in the presence of polybrene. Stably transduced cells were selected under puromycin. The target

Keywords

  • Atg5
  • Raptor
  • ULK1
  • ULK2
  • mTOR

Fingerprint

Dive into the research topics of 'ULK1 inhibits the kinase activity of mTORC1 and cell proliferation'. Together they form a unique fingerprint.

Cite this